Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Akram

Showing results (521-530 of 541) with videos related to

Pageof 55
Sort By:
Journal of Toxicology|August 23, 2021
Toxicity of Nanoparticles in Biomedical Application: NanotoxicologyChukwuebuka Egbuna, Vijaykumar K Parmar, Jaison Jeevanandam, et al.
Blood|September 12, 2022
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agentsAdam D Cohen, María-Victoria Mateos, Yael C Cohen, et al.
The International Journal of Behavioral Nutrition and Physical Activity|November 29, 2024
Associations of perceived neighbourhood and home environments with sedentary behaviour among adolescents in 14 countries: the IPEN adolescent cross sectional observational studyRanjit Mohan Anjana, Harish Ranjani, Ester Cerin, et al.
Blood Cancer Journal|February 25, 2022
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studiesAdam D Cohen, Samir Parekh, Bianca D Santomasso, et al.
Blood Cancer Journal|November 26, 2025
Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4Paula Rodríguez-Otero, Surbhi Sidana, Mathilde Kouwenhoven, et al.
Current Topics in Medicinal Chemistry|May 10, 2021
Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic ReviewChukwuebuka Egbuna, Chinaza G Awuchi, Garima Kushwaha, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 22, 2012
Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcomeNoreen Sabir, Zafar Iqbal, Aamer Aleem, et al.
Environmental Science and Pollution Research International|January 6, 2017
Optimizing the phosphorus use in cotton by using CSM-CROPGRO-cotton model for semi-arid climate of Vehari-Punjab, PakistanAsad Amin, Wajid Nasim, Muhammad Mubeen, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 20, 2026
Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE StudiesPaula Rodríguez-Otero, Jaime Gállego Pérez-Larraya, Yi Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2025
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple MyelomaSundar Jagannath, Thomas G Martin, Yi Lin, et al.
Pageof 55

Showing results (521-530 of 541) with videos related to

Sort By:
Pageof 55
Journal of Toxicology|August 23, 2021
Toxicity of Nanoparticles in Biomedical Application: NanotoxicologyChukwuebuka Egbuna, Vijaykumar K Parmar, Jaison Jeevanandam, et al.
Blood|September 12, 2022
Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agentsAdam D Cohen, María-Victoria Mateos, Yael C Cohen, et al.
The International Journal of Behavioral Nutrition and Physical Activity|November 29, 2024
Associations of perceived neighbourhood and home environments with sedentary behaviour among adolescents in 14 countries: the IPEN adolescent cross sectional observational studyRanjit Mohan Anjana, Harish Ranjani, Ester Cerin, et al.
Blood Cancer Journal|February 25, 2022
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studiesAdam D Cohen, Samir Parekh, Bianca D Santomasso, et al.
Blood Cancer Journal|November 26, 2025
Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4Paula Rodríguez-Otero, Surbhi Sidana, Mathilde Kouwenhoven, et al.
Current Topics in Medicinal Chemistry|May 10, 2021
Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic ReviewChukwuebuka Egbuna, Chinaza G Awuchi, Garima Kushwaha, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 22, 2012
Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcomeNoreen Sabir, Zafar Iqbal, Aamer Aleem, et al.
Environmental Science and Pollution Research International|January 6, 2017
Optimizing the phosphorus use in cotton by using CSM-CROPGRO-cotton model for semi-arid climate of Vehari-Punjab, PakistanAsad Amin, Wajid Nasim, Muhammad Mubeen, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 20, 2026
Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE StudiesPaula Rodríguez-Otero, Jaime Gállego Pérez-Larraya, Yi Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2025
Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple MyelomaSundar Jagannath, Thomas G Martin, Yi Lin, et al.
Pageof 55